Literature DB >> 10585789

Extended-spectrum beta-lactamases: a call for improved detection and control.

D L Paterson, V L Yu.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10585789     DOI: 10.1086/313559

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  20 in total

Review 1.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  Clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases: prevalence of CTX-M-3 at a hospital in China.

Authors:  Hui Wang; Swathi Kelkar; Weiyuan Wu; Minjun Chen; John P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

3.  Outbreak of infection with a multiresistant Klebsiella pneumoniae strain associated with contaminated roll boards in operating rooms.

Authors:  Annemarie van 't Veen; Anneke van der Zee; Jolande Nelson; Ben Speelberg; Jan A J W Kluytmans; Anton G M Buiting
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

4.  Efficient direct extended-spectrum β-lactamase detection by multiplex real-time PCR: accurate assignment of phenotype by use of a limited set of genetic markers.

Authors:  Justin Ellem; Sally R Partridge; Jonathan R Iredell
Journal:  J Clin Microbiol       Date:  2011-05-25       Impact factor: 5.948

5.  Yield of vancomycin-resistant enterococci and multidrug-resistant Enterobacteriaceae from stools submitted for Clostridium difficile testing compared to results from a focused surveillance program.

Authors:  D M Hacek; P Bednarz; G A Noskin; T Zembower; L R Peterson
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

6.  Reply to "selective digestive tract decontamination and spread of colistin resistance: antibiotic prophylaxis is not a substitute for hygiene".

Authors:  Teysir Halaby; Nashwan Al Naiemi; Christina M J E Vandenbroucke-Grauls
Journal:  Antimicrob Agents Chemother       Date:  2014-06       Impact factor: 5.191

7.  Extended-spectrum β-lactamase (ESBL) in Omani Children: Study of prevalence, risk factors and clinical outcomes at Sultan Qaboos University Hospital, Sultanate of Oman.

Authors:  Zakariya Al Muharrmi; Akbar M Rafay; Abdullah Balkhair; Salem Al-Tamemi; Ali Al Mawali; Hilal Al Sadiri
Journal:  Sultan Qaboos Univ Med J       Date:  2008-07

Review 8.  Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.

Authors:  D L Paterson; W C Ko; A Von Gottberg; J M Casellas; L Mulazimoglu; K P Klugman; R A Bonomo; L B Rice; J G McCormack; V L Yu
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

9.  High prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric unit in Madagascar.

Authors:  Todisoa Andriatahina; Frédérique Randrianirina; Eliosa Ratsima Hariniana; Antoine Talarmin; Honoré Raobijaona; Yves Buisson; Vincent Richard
Journal:  BMC Infect Dis       Date:  2010-07-12       Impact factor: 3.090

10.  Effect of parenteral antibiotic administration on establishment of intestinal colonization in mice by Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases.

Authors:  Claudia K Hoyen; Nicole J Pultz; David L Paterson; David C Aron; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.